Olanzapine for treatment of the schizophrenia prodrome: 2-year results of a randomized placebo-controlled study

被引：0
|
作者：
McGlashan, TH
Zipursky, RB
Perkins, DO
Addington, J
Woods, SW
Miller, TJ
Lindborg, SR
Trzaskoma, Q
Hawkins, K
Breier, A
机构：
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ N Carolina, Chapel Hill, NC 27515 USA
[4] Yale Univ, New Haven, CT 06520 USA
[5] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
BIOLOGICAL PSYCHIATRY | 2004年 / 55卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
807
引用
收藏
页码：226S / 226S
页数：1
相关论文
共 50 条
  • [21] Efficacy of lurasidone in schizophrenia: Results of a phase 2, placebo-controlled, study
    Phillips, D.
    Ogasa, M.
    Severs, J.
    Nakamura, M.
    Guarino, J.
    Tamura, N.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 572 - 573
  • [22] A randomized, placebo-controlled trial of intravitreal triamcinolone acetonide for diabetic macular edema that persists or recurs after laser treatment - 2-year results
    Gillies, MC
    Zhu, M
    Simpson, JM
    Sutter, FKP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [23] PLACEBO-CONTROLLED STUDY OF TERAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH 2-YEAR FOLLOW-UP
    FABRICIUS, PG
    MACHANNAFORD, J
    BRITISH JOURNAL OF UROLOGY, 1992, 70 : 10 - 16
  • [24] A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania
    Van Ameringen, Michael
    Mancini, Catherine
    Patterson, Beth
    Bennett, Mark
    Oakman, Jonathan
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (10) : 1336 - 1343
  • [25] Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
    Boonen, Steven
    Lorenc, Roman S.
    Wenderoth, Dietrich
    Stoner, Karen J.
    Eusebio, Rachelle
    Orwoll, Eric S.
    BONE, 2012, 51 (03) : 383 - 388
  • [26] A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
    Chang, William Y. C.
    Cane, Jennifer L.
    Kumaran, Maruti
    Lewis, Sarah
    Tattersfield, Anne E.
    Johnson, Simon R.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (04) : 1114 - 1123
  • [27] Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
    Woods, SW
    Breier, A
    Zipursky, RB
    Perkins, DO
    Addington, J
    Miller, TJ
    Hawkins, KA
    Marquez, E
    Lindborg, SR
    Tohen, M
    McGlashan, TH
    BIOLOGICAL PSYCHIATRY, 2003, 54 (04) : 453 - 464
  • [28] Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Phillips, Debra
    Xu, Jane
    Kalali, Amir H.
    Schweizer, Edward
    Pikalov, Andrei
    Loebel, Antony
    AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (09): : 957 - 967
  • [29] Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study
    Hassanpour, Fatemeh
    Zarghami, Mehran
    Mouodi, Sussan
    Moosazadeh, Mahmood
    Barzegar, Fatemeh
    Bagheri, Maedeh
    Hendouei, Narjes
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 634 - 638
  • [30] Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia
    Emsley, R
    Myburgh, C
    Oosthuizen, P
    van Rensburg, SJ
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (09): : 1596 - 1598
12345